Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
9
×
tc
9
×
bio
health
biology
biotechnology
non-coding rna
repetitive dna sequences
american biochemists
berkeley college of chemistry faculty
crystallographers
editas medicine
emerging technologies
enzymes
genetics
harvard university alumni
howard hughes medical investigators
jennifer doudna
living people
medicine
members of the united states national academy of sciences
molecular biology
science
university of california
yale department of molecular biophysics & biochemistry faculty
1861 establishments in massachusetts
1963 births
1987 establishments in texas
23andme
american women scientists
annual events in texas
antibiotic resistance
antimicrobial
applied genetics
association of american universities
berkeley
bill gates
bioethics
biological engineering
biotech
What
technology
9
×
crispr
cas
editing
gene
read
using
biotech
genetic
antibiotic
berkeley
called
centers
chemistry
doudna
enzyme
future
industry
inventor
jennifer
molecular
patent
public
scientists
snip
stage
testing
today
use
year
ability
according
acts
advances
afternoon
aids
alexandria
allowing
ambitious
andme
Language
Current search:
technology
×
crispr
×
tc
×
@techcrunch.com
5 years ago
HP is ‘printing’ drugs for the CDC to speed up antibiotic testing
@techcrunch.com
6 years ago
Scientists have eliminated HIV in mice using CRISPR
@techcrunch.com
7 years ago
CRISPR pioneer Jennifer Doudna shines hope on the future of genetic modification at SXSW
@techcrunch.com
7 years ago
Judge rules CRISPR-Cas9 patents belong to Broad Institute of Harvard and MIT
@techcrunch.com
7 years ago
Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis
@techcrunch.com
7 years ago
CRISPR loses Nobel to tiny machines
@techcrunch.com
7 years ago
Jennifer Doudna, inventor of gene editing technology CRISPR Cas9, is coming to Disrupt
@techcrunch.com
8 years ago
Innovation in genomics and the future of medtech
@techcrunch.com
8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute